Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,866Revenue (TTM) $M117Net Margin (%)7.7Altman Z-Score6.1
Enterprise Value $M2,912EPS (TTM) $0.4Operating Margin %41.1Piotroski F-Score5
P/E(ttm)358Beneish M-Score-2.6Pre-tax Margin (%)19.6Higher ROA y-yN
Price/Book7.410-y EBITDA Growth Rate %--Quick Ratio0.8Cash flow > EarningsY
Price/Sales26.05-y EBITDA Growth Rate %--Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow41.7y-y EBITDA Growth Rate %28.2ROA % (ttm)1.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)2.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.1ROIC % (ttm)3.3Gross Margin Increase y-yN

Gurus Latest Trades with LGND

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

LGND is held by these investors:



LGND: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HIGGINS JOHN LCEO 2017-09-05Sell5,000$1304.72view
Aryeh JasonDirector 2017-08-23Sell2,000$127.996.37view
FOEHR MATTHEW WPresident and COO 2017-08-09Sell6,100$127.516.77view
Berkman Charles SVP, Gen. Counsel & Secretary 2017-08-09Sell18,625$126.967.23view
HIGGINS JOHN LCEO 2017-08-08Sell5,483$1258.91view
HIGGINS JOHN LCEO 2017-06-21Sell4,666$12013.45view
HIGGINS JOHN LCEO 2017-06-09Sell12,000$114.8718.52view
Aryeh JasonDirector 2017-05-12Sell37,247$110.7622.91view
FOEHR MATTHEW WPresident and COO 2017-05-12Sell5,621$112.221.34view
HIGGINS JOHN LCEO 2017-03-20Sell4,000$109.124.78view

Quarterly/Annual Reports about LGND:

News about LGND:

Articles On GuruFocus.com
Gurus Invest in Top Biotechnology Stocks Jun 20 2016 
RS Investment Increases Holdings in Ulta Salon, Noble Energy and Fortune Brands Dec 23 2015 
Dan Loeb Sees Opportunity in Latest Activist Target Baxter International Aug 06 2015 
Dan Loeb Sees Opportunity in Latest Activist Target Baxter International Aug 06 2015 
Ligand Pharmaceuticals - Severe competitive threat to key royalty program and “going concern” ri Jun 19 2014 
5 Hot Stocks to Consider Now Mar 30 2012 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) May 05 2010 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 09 2009 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 04 2009 

More From Other Websites
Alcoa, Cheesecake Factory, Luminex, Ligand Pharmaceuticals and Centene highlighted as Zacks Bull and... Sep 20 2017
3 Healthcare Stocks to Buy on Renewed Obamacare Repeal Talks Sep 19 2017
Glaxo's Shingles Candidate Gets Positive FDA Committee Vote Sep 14 2017
5 Top-Ranked Biotech Stocks to Buy Right Now Sep 11 2017
See what the IHS Markit Score report has to say about Ligand Pharmaceuticals Inc. Sep 11 2017
Lilly to Cut 3,500 Jobs to Invest in New Drugs and Growth Sep 08 2017
Alnylam Shares Plunge on Patient Death, Dosing Suspended Sep 08 2017
Ligand (LGND) Up 9.6% Since Earnings Report: Can It Continue? Sep 07 2017
Captisol-Enabled Prexasertib May Be Major Growth Driver for Ligand Sep 06 2017
Brexanolone Could Strengthen Ligand’s Neurology Portfolio Sep 06 2017
Sparsentan May Be Solid Near-Term Growth Driver for Ligand Sep 06 2017
Ligand (LGND) Diabetes Candidate Positive in Phase II Study Sep 06 2017
Biotech Stock Roundup: Cellectis Down on Clinical Hold, Insmed Soars on Positive Data Sep 06 2017
4 Biotech Stocks to Improve Your Portfolio's Health Sep 05 2017
Analyst Makes The Case For Ligand As A 'Core' Holding Sep 05 2017
Ligand Announces Top-Line Results from Phase 2 Study of LGD-6972 in Patients with Type 2 Diabetes Sep 05 2017
Baxdela Is Expected to Boost Ligand Pharmaceuticals’ Revenues Sep 04 2017
Amgen Gets EU Nod to Expand Hyperparathyroidism Drug Label Sep 01 2017
Evomela’s Market Share Is Increasing in 2017 Sep 01 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}